Tenet Healthcare (THC) Can Underperform, In-Line Guidance Bold - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $245.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
